Core Scientific, Inc. CORZ
Set alert
12.77 USD -0.48 -3.62%
As of Nov 2, 1:35 PM ET
12.65 Day range 13.38
12.31 52-week range 30.46
- YTD
- -12.29%
- 1 year
- -40.71%
- Open
- 13.32
- Prev close
- 13.25
- Mkt cap
- 4.11B
- Vol
- 5.40M
- Avg vol
- 12.75M
- EPS
- -4.25
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.65
- High
- 13.38
- Forward P/E
- 79.41
- Beta
- 5.48
- Short ratio
- 5.77
- Inst. own
- 120.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 16.29
- 200-d avg
- 19.68
- 1y target
- 31.48
MAX chart
Events in this range
- Aug 8, 2025Earnings: -0.04; estimate -0.07; surprise 42.86%
- Oct 24, 2025Earnings: -0.46; estimate -0.06981; surprise -558.93%
- Mar 2, 2026Earnings: -0.42; estimate -0.16356; surprise -156.79%
- May 6, 2026Earnings: -1.06; estimate -0.02; surprise -5200%
- Jul 28, 2026Earnings: -3.32; estimate -0.06262; surprise -5201.82%
- Sep 23, 2026Rating: UBS · — → Buy
- Oct 14, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Oct 15, 2026Rating: BTIG · Buy → Buy
- Oct 15, 2026Rating: Canaccord Genuity · Buy → Buy
- Oct 16, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Oct 30, 2026Rating: B. Riley Securities · Buy → Buy
- Nov 5, 2026Earnings: —; estimate -0.04561; surprise —%
Signals (47)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 10, 2025 | 11 months ago |
| RSI: Overbought | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| RSI: Overbought | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 16, 2024 | 1 year ago |
| RSI: Overbought | Nov 4, 2024 | 1 year ago |
| RSI: Overbought | Oct 21, 2024 | 2 years ago |
| RSI: Overbought | Oct 7, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 23, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| RSI: Overbought | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| RSI: Overbought | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| SMA: Bearish | Apr 29, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
Financial health
Altman Z-Score
-2.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -16.5×
FY 2019 5y median -2.7× FY 2025
P/S 14.5×
FY 2019 5y median 2.6× FY 2025
P/B -4.8×
FY 2019 5y median -2.9× FY 2025
P/FCF -10.3×
FY 2019 5y median -6.1× FY 2025
EV/EBITDA -25.9×
FY 2019 5y median -3.4× FY 2025
EV/Sales 16.9×
FY 2019 5y median 4.2× FY 2025
FCF Yield -9.7%
FY 2019 5y median -9.7% FY 2025
Profitability
Gross Margin 11.9%
FY 2019 5y median 23.7% FY 2025
Operating Margin -70.4%
FY 2019 5y median -3.8% FY 2025
Net Margin -90.5%
FY 2019 5y median -90.5% FY 2025
ROE 30.0%
FY 2019 5y median 41.3% FY 2025
ROIC -14.3%
FY 2019 5y median -1.3% FY 2025
ROA -12.3%
FY 2019 5y median -34.6% FY 2025
Growth (YoY)
Revenue -37.5%
FY 2019 FY 2025
Operating Income -1069.8%
FY 2019 FY 2025
EPS (diluted) 82.9%
FY 2019 FY 2025
Free Cash Flow -765.7%
FY 2019 FY 2025
Financial Health
Current Ratio 1.1×
FY 2019 5y median 1.1× FY 2025
Quick Ratio 1.1×
FY 2019 5y median 1.1× FY 2025
Debt / Equity -1.1×
FY 2019 5y median -1.1× FY 2025
Net Debt / EBITDA -3.6×
FY 2019 5y median -0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31